ENTO logo

Entero Therapeutics, Inc. (ENTO)

Profile

Full Name

Entero Therapeutics, Inc.

Ticker

NASDAQ: ENTO

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

October 11, 2016

Indexes

Not included

Website

https://www.enterothera.com

Employees

2

Key Details

Price

$2.16(+18.03%)

Market cap

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$0.00(0.00% YoY)

Annual EPS

-$5.33(+88.87% YoY)

PE ratio

-

Next earnings date

Oct 21, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $2.16
    ENTO price is $2.16

    30-Day Relative Volume

    0.11
    ENTO 30-day relative volume is 0.11

    Price Performance

    Price Most recent change

    +18.03%
    ENTO price was up +18.03% on Aug 18, 2025

    Price YTD change

    +15.76%
    ENTO price is up +15.76% since January 1st

    Price 1-year change

    +142.1%
    ENTO price is up +142.1% year-on-year

    Price 3-year change

    -99.89%
    ENTO price is down -99.89% over the past 3 years

    Price Range

    Price All-time high

    $705.60K
    ENTO price is currently -100.00% below its historical high of $705.60 thousand

    Price 3-year low

    $0.56
    ENTO price is currently +289.19% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $10.29M
    ENTO market capitalization is $10.29 million

    Market cap 3-year change

    -46.73%
    ENTO market capitalization is down -46.73% over the past 3 years

    Market cap All-time high

    $303.91M
    ENTO market capitalization is currently -96.61% below its historical high of $303.91 million

    Market cap sector rank

    16.5%
    ENTO market capitalization is higher than 16.5% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +339.48%
    ENTO shares outstanding is up +339.48% year-on-year

    Shares Outstanding 3-Year Change

    +48038.38%
    ENTO shares outstanding is up +48038.38% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.44
    ENTO beta is 0.44

    200-day SMA

    $1.51
    ENTO price is currently +43.21% above its 200-day simple moving average

    50-day SMA

    $1.47
    ENTO price is currently +47.22% above its 50-day simple moving average

    RSI

    71.35
    ENTO 14-day relative strength index is 71.35

    Volume

    0.11
    ENTO 30-day relative volume is 0.11

    ATR

    $0.28
    ENTO average true range is $0.28

    10-day Historical Volatility

    356.05%
    ENTO 10-day historical volatility is 356.05%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $0.00
    ENTO annual revenue is $0.00

    Revenue Analysts estimate

    -
    ENTO annual revenue consensus analysts' forecast is unknown

    Revenue 1-year change

    0%
    ENTO annual revenue has remained unchanged year-on-year

    Revenue Sector rank

    28.58%
    ENTO annual revenue is higher than 28.58% of companies in Healthcare sector

    EPS

    EPS

    -$5.33
    ENTO annual earnings per share is -$5.33

    EPS Analysts estimate

    -$1.52
    ENTO annual earnings per share is currently +250.66% higher than the consensus analysts' forecast

    EPS 1-year change

    +88.87%
    ENTO annual earnings per share is up +88.87% year-on-year

    EPS Sector rank

    18.77%
    ENTO annual earnings per share is higher than 18.77% of companies in Healthcare sector

    Profit

    Gross profit

    -$48.90K
    ENTO annual gross profit is -$48.90 thousand

    Gross margin

    -
    ENTO annual gross profit margin value is unknown

    Operating profit

    -$15.62M
    ENTO annual operating income is -$15.62 million

    Operating margin

    -
    ENTO annual operating profit margin value is unknown

    Net income

    -$15.62M
    ENTO annual net profit is -$15.62 million

    Net margin

    -
    ENTO annual net profit margin value is unknown

    Expenses

    Total expenses

    $15.62M
    ENTO annual total expenses is $15.62 million

    Operating expenses

    $15.57M
    ENTO annual total operating expenses is $15.57 million

    Cost of goods sold

    $48.90K
    ENTO annual cost of goods sold is $48.90 thousand

    Selling, general & administrative expenses

    $0.00
    ENTO annual SGA is $0.00

    Depreciation and amortization

    $48.90K
    ENTO annual depreciation & amortization is $48.90 thousand

    Interest expense

    $0.00
    ENTO annual interest expense is $0.00

    Income tax

    $0.00
    ENTO annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$15.62M
    ENTO annual earnings before interest & taxes is -$15.62 million

    EBITDA

    -$15.57M
    ENTO annual EBITDA is -$15.57 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $85.41M
    ENTO annual total assets is $85.41 million

    Non current assets

    $1.93M
    ENTO annual long term assets is $1.93 million

    Current assets

    $83.48M
    ENTO annual total current assets is $83.48 million

    Cash and cash equivalents

    $163.50K
    ENTO annual cash & cash equivalents is $163.50 thousand

    Accounts receivable

    -
    ENTO annual accounts receivable value is unknown

    Inventory

    $0.00
    ENTO annual inventory is $0.00

    Liabilities

    Total liabilities

    $27.61M
    ENTO annual total liabilities is $27.61 million

    Long term liabilities

    $59.00K
    ENTO annual total long term liabilities is $59.00 thousand

    Current liabilities

    $27.55M
    ENTO annual total current liabilities is $27.55 million

    Accounts payable

    $2.96M
    ENTO annual accounts payable is $2.96 million

    Debt

    Total debt

    $140.50K
    ENTO annual total debt is $140.50 thousand

    Total debt 1-year change

    -83.01%
    ENTO annual total debt is down -83.01% year-on-year

    Long term debt

    $59.00K
    ENTO annual long term debt is $59.00 thousand

    Short term debt

    $81.50K
    ENTO annual short term debt is $81.50 thousand

    Equity & Capital

    Shareholders equity

    $57.80M
    ENTO annual stockholders equity is $57.80 million

    Book value

    -$3.88M
    ENTO annual book value is -$3.88 million

    Retained earnings

    -$202.39M
    ENTO annual retained earnings is -$202.39 million

    Working capital

    $55.93M
    ENTO annual working capital is $55.93 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    -$9.22M
    ENTO annual cash flow from operations is -$9.22 million

    Cash from operations 1-year change

    +25.53%
    ENTO annual cash flow from operations is up +25.53% year-on-year

    Cash from investing

    $88.20K
    ENTO annual cash flow from investing activities is $88.20 thousand

    Cash from investing 1-year change

    +117.64%
    ENTO annual cash flow from investing activities is up +117.64% year-on-year

    Cash from financing

    $5.58M
    ENTO annual cash flow from financing activities is $5.58 million

    Cash from financing 1-year change

    -63.34%
    ENTO annual cash flow from financing activities is down -63.34% year-on-year

    CAPEX

    CAPEX

    $0.00
    ENTO annual capital expenditures is $0.00

    CAPEX 1-year change

    -100%
    ENTO annual capital expenditures is down -100% year-on-year

    Free Cash Flow

    Free cash flow

    -$9.22M
    ENTO annual free cash flow is -$9.22 million

    Free cash flow 1-year change

    +28.42%
    ENTO annual free cash flow is up +28.42% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    -
    ENTO annual gross profit margin value is unknown

    Operating margin

    -
    ENTO annual operating profit margin value is unknown

    Net margin

    -
    ENTO annual net profit margin value is unknown

    ROA & ROE

    ROA

    -33.85%
    ENTO annual return on assets is -33.85%

    ROE

    -50.87%
    ENTO annual return on equity is -50.87%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    ENTO price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    ENTO price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -1.63
    ENTO price to book ratio is -1.63

    PB ratio Sector rank

    9.48%
    ENTO price to book ratio is higher than 9.48% of companies in Healthcare sector

    PS Ratio

    PS ratio

    -
    ENTO price to sales ratio value is unknown

    PS ratio Sector rank

    -
    ENTO price to sales ratio is unknown

    Enterprise value

    Enterprise value

    $10.29M
    ENTO enterprise value is $10.29 million

    Enterprise value Sector rank

    26.38%
    ENTO enterprise value is higher than 26.38% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -2.26
    ENTO EV/EBITDA is -2.26

    EV/EBITDA Sector rank

    32.27%
    ENTO EV/EBITDA is higher than 32.27% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    3.03
    ENTO annual current ratio is 3.03

    Quick ratio

    3.03
    ENTO annual quick ratio is 3.03

    Leverage

    Debt to equity

    0.00
    ENTO annual debt to equity ratio is 0.00

    Interest coverage ratio

    -
    ENTO annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    -
    ENTO piotroski f-score value is unknown

    Altman Z-Score

    -2.91
    ENTO altman z-score is -2.91

    Analyst ratings

    Recent major analysts updates

    Mar 15, 24 Roth MKM
    Buy
    Jan 3, 24 Roth MKM
    Buy

    Institutional Ownership

    Screeners with ENTO included

    Growing Shares Outstanding
    US stocks
    Stocks with high beta
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    • What is the ticker symbol for Entero Therapeutics, Inc.?
    • Does Entero Therapeutics, Inc. pay dividends?
    • What sector is Entero Therapeutics, Inc. in?
    • What industry is Entero Therapeutics, Inc. in?
    • What country is Entero Therapeutics, Inc. based in?
    • When did Entero Therapeutics, Inc. go public?
    • Is Entero Therapeutics, Inc. in the S&P 500?
    • Is Entero Therapeutics, Inc. in the NASDAQ 100?
    • Is Entero Therapeutics, Inc. in the Dow Jones?
    • When was Entero Therapeutics, Inc.'s last earnings report?
    • When does Entero Therapeutics, Inc. report earnings?

    What is the ticker symbol for Entero Therapeutics, Inc.?

    The ticker symbol for Entero Therapeutics, Inc. is NASDAQ:ENTO

    Does Entero Therapeutics, Inc. pay dividends?

    No, Entero Therapeutics, Inc. does not pay dividends

    What sector is Entero Therapeutics, Inc. in?

    Entero Therapeutics, Inc. is in the Healthcare sector

    What industry is Entero Therapeutics, Inc. in?

    Entero Therapeutics, Inc. is in the Biotechnology industry

    What country is Entero Therapeutics, Inc. based in?

    Entero Therapeutics, Inc. is headquartered in United States

    When did Entero Therapeutics, Inc. go public?

    Entero Therapeutics, Inc.'s initial public offering (IPO) was on October 11, 2016

    Is Entero Therapeutics, Inc. in the S&P 500?

    No, Entero Therapeutics, Inc. is not included in the S&P 500 index

    Is Entero Therapeutics, Inc. in the NASDAQ 100?

    No, Entero Therapeutics, Inc. is not included in the NASDAQ 100 index

    Is Entero Therapeutics, Inc. in the Dow Jones?

    No, Entero Therapeutics, Inc. is not included in the Dow Jones index

    When was Entero Therapeutics, Inc.'s last earnings report?

    Entero Therapeutics, Inc.'s most recent earnings report was on May 15, 2025

    When does Entero Therapeutics, Inc. report earnings?

    The next expected earnings date for Entero Therapeutics, Inc. is October 21, 2025
    On this page